Point72 Hong Kong LTD Alector, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $56,076 - $90,380	6,847 New	6,847 $65,000
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $73,707 - $137,202	-9,635 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $83,510 - $133,282	6,414 Added 199.13%	9,635 $137,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $31,385 - $41,425	-1,622 Reduced 33.49%	3,221 $67,000
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $77,723 - $141,769	3,590 Added 286.51%	4,843 $111,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $19,421 - $28,167	1,253 New	1,253 $26,000
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $19,203 - $45,477	-1,822 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $39,847 - $60,326	1,822 New	1,822 $45,000

167

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $149M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.